M.Sc. Translational Oncology
Course Overview
This M.Sc. in Translational Oncology provides high-quality training for scientists and clinicians, bridging the gap between laboratory research and patient care in cancer treatment. The program focuses on the molecular basis of cancer and covers the latest advancements in targeted and immune-based therapies. Students will develop essential research skills through a dedicated dissertation project conducted within Trinity College Dublin's renowned oncology network.
Key Program Highlights
- Research-led teaching from leaders in the field, integrating both scientific and clinical perspectives
- Comprehensive curriculum covering tumor immunology, molecular targeted therapies, cancer epigenetics, and clinical trials
- Focus on cutting-edge, individualized treatment strategies and drug development
- Hands-on research experience culminating in a dissertation project with affiliated oncology groups
- Designed for both basic scientists and clinicians to foster collaboration in translational cancer research
Course Overview
This M.Sc. in Translational Oncology provides high-quality training for scientists and clinicians, bridging the gap between laboratory research and patient care in cancer treatment. The program focuses on the molecular basis of cancer and covers the latest advancements in targeted and immune-based therapies. Students will develop essential research skills through a dedicated dissertation project conducted within Trinity College Dublin's renowned oncology network.
Key Program Highlights
- Research-led teaching from leaders in the field, integrating both scientific and clinical perspectives
- Comprehensive curriculum covering tumor immunology, molecular targeted therapies, cancer epigenetics, and clinical trials
- Focus on cutting-edge, individualized treatment strategies and drug development
- Hands-on research experience culminating in a dissertation project with affiliated oncology groups
- Designed for both basic scientists and clinicians to foster collaboration in translational cancer research